The US regulatory agency has just started a priority review of Imfinzi (durvalumab), in combination with Pfizer and ...

FDA Commissioner nominee Heidi Overton deflected multiple questions about her willingness to stand up to pressure from ...

These specialised professionals work alongside sites to uncover recruitment challenges early, using clinical expertise and ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...

The Swiss pharma group has just reported topline results from the phase 3 IMAgINATION study of Factor B inhibitor sefaxersen ...

Adding ITM will also give Telix a pipeline of follow-up radiopharma candidates, including clinical-stage diagnostics and ...

AI-powered drug discovery companies Enveda Biosciences and Basecamp Research have completed impressive funding rounds – worth ...

Dazodalibep is one of the assets included in Amgen's near-$28 billion takeover of Horizon Pharma in 2023, which also gave it ...

The FDA has approved Eli Lilly's once-weekly basal insulin product Onswik for adults with type 2 diabetes, setting up a market tussle with Novo over its recently launched Awiqli. Onswik (insulin ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

The FDA's experts looked at data from NHS-Galleri, as well as the US and Canadian PATHFINDER 2 study, which enrolled more than 35,000 subjects and showed that the test was able to increase cancer ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...